MODTX — Modus Therapeutics Holding AB Share News
0.000.00%
Last trade - 00:00- SEK27.44m
- SEK14.95m
Brief: Karolinska Development Portfolio Co Secures Bridge Financing
Brief: Modus Therapeutics Secures Access To Bridge Financing Of Up To SEK 5 Mln
Brief: Modus Therapeutics Q2 Net Loss Stable At SEK 4.7 Mln
Brief: Modus Therapeutics Q2 Net Income SEK -4.738 Million
Brief: Modus Therapeutics Decides That No Dividend Will Be Paid
Brief: Modus Therapeutics Q1 Net Income SEK -3.105 Million
Brief: Modus Therapeutics Q4 Net Loss Narrows To SEK 4.1 Mln
Brief: Modus Therapeutics Raises SEK 19.4 Mln In Rights Issue
Brief: Modus Therapeutics Carries Out Rights Issue Of SEK 40.3 Mln
Brief: Modus Therapeutics Q3 Net Income SEK -3.093 Million
Brief: Modus Therapeutics Q2 EPS at SEK -0.29
Brief: Modus Therapeutics Q1 Loss SEK 6.0 Mln
Brief: Modus Therapeutics Q1 Net Income at SEK -6 Million
Brief: Modus Therapeutics Secures Bridge Financing From Karolinska Development
Brief: Modus Therapeutics Holding Q4 Loss After Tax Narrows To SEK 9.4 Mln
Brief: Modus Therapeutics Submits Patent Application For Sevuparin
Brief: Modus Therapeutics Q3 Loss After Tax Narrows To SEK 2.9 Mln
Advisory: Alert wrongly tagged to Modus Therapeutics withdrawn
Advisory: Alert wrongly tagged to Modus Therapeutics withdrawn